Cibra Capital LTD has filed its 13F form on April 28, 2025 for Q1 2025 where it was disclosed a total value porftolio of $293 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Intra Cellular Therapies, Inc. with a value of $54.9B, Kellogg CO with a value of $37.1B, Berry Global Group, Inc. with a value of $29.6B, Hess Corp with a value of $27.7B, and Despegar.Com, Corp. with a value of $25.2B.

Examining the 13F form we can see an increase of $146B in the current position value, from $147B to 293B.

Cibra Capital LTD is based out at London, X0

Below you can find more details about Cibra Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $293 Billion
Healthcare: $96.4 Billion
Consumer Cyclical: $60.9 Billion
Consumer Defensive: $37.1 Billion
Industrials: $30 Billion
Energy: $27.7 Billion
Communication Services: $24.6 Billion
Financial Services: $11.2 Billion
Technology: $2.34 Billion
Other: $2.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $293 Billion
  • Prior Value $147 Billion
  • Filing
  • Period Q1 2025
  • Filing Date April 28, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 13 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Cibra Capital LTD Portfolio

Follow Cibra Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibra Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cibra Capital LTD with notifications on news.